• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by AdvanSix Inc.

    6/20/25 4:20:25 PM ET
    $ASIX
    Major Chemicals
    Industrials
    Get the next $ASIX alert in real time by email
    S-8 1 s-8incentiveplanxjune202025.htm S-8 Document

    As filed with the Securities and Exchange Commission on June 20, 2025
    Registration No. 333-

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM S-8
    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 
    AdvanSix Inc.
    (Exact name of registrant as specified in its charter)
    Delaware 81-2525089
    (State or other jurisdiction of
    incorporation or organization)
     (I.R.S. Employer
    Identification No.)
    300 Kimball Drive, Suite 101
    Parsippany, New Jersey 07054
    (Address, including zip code, of registrant’s principal executive offices)
     
    2016 Stock Incentive Plan of AdvanSix Inc. and its Affiliates, as Amended and Restated
    (Full title of the plan)
     
    Erin N. Kane
    President and Chief Executive Officer
    AdvanSix Inc.
    300 Kimball Drive, Suite 101
    Parsippany, New Jersey 07054
    (973) 526-1800
    (Name, address, including zip code, and telephone number, including area code, of agent for service)
     
    Copies to:
    Achilles B. Kintiroglou
    Senior Vice President, General Counsel,
     and Corporate Secretary
    AdvanSix Inc.
    300 Kimball Drive, Suite 101
    Parsippany, New Jersey 07054
    (973) 526-1800
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated filer [X]Accelerated Filer [ ]
    Non-accelerated filer [ ]Smaller reporting company [ ]
    Emerging growth company [ ]
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. [ ]
     



    EXPLANATORY NOTE

    Registration of Additional Securities

    On June 18, 2025, the stockholders of AdvanSix Inc. (the “Company”) approved the 2016 Stock Incentive Plan of AdvanSix Inc. and its Affiliates, as Amended and Restated (the “2016 Plan”) to increase the number of shares of common stock, par value $0.01 per share ("Common Stock"), available under the 2016 Plan by 1,400,000 shares and to implement certain additional amendments summarized in Proposal No. 4 in the Company’s definitive proxy statement filed with the Securities and Exchange Commission (the “Commission”) on April 29, 2025, as supplemented on May 16, 2025. This Registration Statement is being filed with the Commission pursuant to General Instruction E to Form S-8 under the Securities Act of 1933, as amended (the "Securities Act"), to register the 1,400,000 additional shares of Common Stock under the 2016 Plan. This Registration Statement hereby incorporates by reference the contents of the Company’s Registration Statement on Form S-8 filed with the Commission on September 30, 2016 (Registration No. 333-213914), which registered 3,350,000 shares of Common Stock under the 2016 Plan, the Company's Registration Statement on Form S-8 filed with the Commission on June 23, 2020 (Registration No. 333-239394), which registered 2,937,209 shares of Common Stock under the 2016 Plan, and the Company's Registration Statement on Form S-8 filed with the Commission on June 16, 2022 (Registration No. 333-265659), which registered 1,730,000 shares of Common Stock under the 2016 Plan (collectively, the “Original Registration Statements”), except to the extent supplemented, amended or superseded by the information set forth herein. Any items in the Original Registration Statements not expressly changed hereby shall be as set forth in the Original Registration Statements.

    Part II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 3.     Incorporation of Documents by Reference.

    The following documents, which have been filed with the Commission by the Company, pursuant to the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as applicable, are hereby incorporated by reference in, and shall be deemed to be a part of, this Registration Statement:

    (a)
    the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Commission on February 21, 2025;
    (b)
    the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the Commission on May 2, 2025;
    (c)
    the Company’s Current Reports on Form 8-K, filed with the Commission on February 21, 2025, March 17, 2025, April 16, 2025, May 2, 2025 and June 20, 2025; and
    (d)
    the description of Common Stock, which is contained in Exhibit 4.1 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed with the Commission on February 21, 2020.

    All documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all such securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents.

    Notwithstanding the foregoing, nothing in this Registration Statement shall be deemed to incorporate the information furnished pursuant to Item 2.02 or Item 7.01 of any Current Report on Form 8-K, unless otherwise expressly stated therein, including any exhibits to the extent furnished in connection with such items.

    Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein (or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein) modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.




    Item 5.     Interests of Named Experts and Counsel.

    The opinion as to the legality of the securities registered hereunder is being given by Achilles B. Kintiroglou, Senior Vice President, General Counsel and Corporate Secretary of the Company. As of June 10, 2025, Mr. Kintiroglou is the beneficial owner of 2,088 shares of Common Stock and options to purchase 55,607 shares of Common Stock. Mr. Kintiroglou is also eligible to participate in the 2016 Plan.

    Item 6. Indemnification of Directors and Officers.

    The General Corporation Law of the State of Delaware (the “DGCL”) authorizes corporations to limit or eliminate the personal liability of directors and officers to corporations and their stockholders for monetary damages for breaches of fiduciary duties as directors or officers, as applicable, except (i) in cases where the director or officer breached his or her duty of loyalty to the corporation or its stockholders, failed to act in good faith, engaged in intentional misconduct or a knowing violation of the law, (ii) in cases where the director willfully or negligently authorized the unlawful payment of a dividend or approved an unlawful stock redemption or repurchase or obtained an improper personal benefit or, (iii) with respect to officers, in any action by or in the right of the corporation. The Company’s Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”) includes such exculpation provisions for its directors and officers.

    The Company’s Amended and Restated By-laws (the “By-laws”) and Certificate of Incorporation also include provisions that indemnify, to the fullest extent permitted or required by the DGCL, the personal liability of directors, officers or employees against all expenses, liabilities and losses for actions taken as a director, officer, employee or agent of the Company, or for serving at the Company’s request as a director, officer, employee or agent at another corporation, partnership, joint venture, trust or other enterprise, as the case may be. The By-laws and Certificate of Incorporation also provide that the Company must indemnify and advance reasonable expenses to the Company’s directors, officers and employees, subject to the Company’s receipt of an undertaking from the indemnified party as may be required under the DGCL. The By-laws also expressly authorize the Company to purchase and maintain insurance to protect the Company, its directors, officers and employees against certain liabilities.

    The limitation of liability and indemnification provisions that are included in the By-laws and Certificate of Incorporation may discourage stockholders from bringing a lawsuit against directors or officers for breach of their fiduciary duties. These provisions may also have the effect of reducing the likelihood of derivative litigation against the Company’s directors and officers, even though such an action, if successful, might otherwise benefit the Company and its stockholders. However, these provisions will not limit or eliminate the Company’s rights, or those of any stockholder, to seek non-monetary relief such as injunction or rescission in the event of a breach of a director’s or officer’s duty of care. The provisions do not alter the liability of directors or officers under the federal securities laws. In addition, your investment may be adversely affected to the extent that, in a class action or direct suit, the Company pays the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.

    Item 8.     Exhibits.
    4.1
    Amended and Restated Certificate of Incorporation of AdvanSix Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q filed on August 1, 2019)
    4.2
    Certificate of Amendment of Amended and Restated Certificate of Incorporation of AdvanSix Inc.
    4.3
    Amended and Restated By-laws of AdvanSix Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on June 20, 2023)
    4.4
    2016 Stock Incentive Plan of AdvanSix Inc. and its Affiliates, as Amended and Restated (effective June 18, 2025) (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on June 20, 2025)
    5.1
    Opinion of Achilles B. Kintiroglou, Senior Vice President, General Counsel and Corporate Secretary of the Registrant, with respect to the legality of the shares being registered.
    23.1
    Consent of PricewaterhouseCoopers LLP.
    24.1
    Power of Attorney (included on signature page to this Registration Statement).
    107
    Filing Fee Table.




    SIGNATURES
     Pursuant to the requirements of the Securities Act, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Parsippany, State of New Jersey, on the 20th day of June, 2025.
    ADVANSIX INC. 
    By: /s/ Erin N. Kane
    Name:Erin N. Kane 
    Title:Chief Executive Officer 

    KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Erin N. Kane, Siddharth Manjeshwar, and Achilles B. Kintiroglou and each of them, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Commission, granting unto each said attorney-in-fact and agents full power and authority to do and perform each and every act in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or either of them or their or his or her substitute or substitutes may lawfully do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
     Name
     
     Title
     
     Date
    /s/ Erin N. Kane President and Chief Executive Officer and Director June 20, 2025
    Erin N. Kane (Principal Executive Officer)  
    /s/ Siddharth Manjeshwar Senior Vice President and Chief Financial Officer June 20, 2025
    Siddharth Manjeshwar (Principal Financial Officer)  
    /s/ Rachael E. Ryan Vice President, Controller and Chief Accounting Officer  June 20, 2025
    Rachael E. Ryan (Principal Accounting Officer)  
    /s/ Todd D. Karran Director June 20, 2025
    Todd D. Karran    
    /s/ Gena C. Lovett, Ph.D. Director June 20, 2025
    Gena C. Lovett, Ph.D.    
    /s/ Donald P. NewmanDirectorJune 20, 2025
    Donald P. Newman
    /s/ Daniel F. Sansone Director June 20, 2025
    Daniel F. Sansone    
    /s/ Sharon S. Spurlin Director June 20, 2025
    Sharon S. Spurlin    
    /s/ Patrick S. WilliamsDirectorJune 20, 2025
    Patrick S. Williams


    Get the next $ASIX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASIX

    DatePrice TargetRatingAnalyst
    5/19/2025$32.00Neutral → Overweight
    Piper Sandler
    4/7/2025$26.00Overweight → Neutral
    Piper Sandler
    11/12/2021$58.00Overweight
    Piper Sandler
    More analyst ratings

    $ASIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Roberts Daryl claimed no ownership of stock in the company (SEC Form 3)

    3 - AdvanSix Inc. (0001673985) (Issuer)

    9/8/25 5:23:30 PM ET
    $ASIX
    Major Chemicals
    Industrials

    New insider O'Brien Dana C. claimed no ownership of stock in the company (SEC Form 3)

    3 - AdvanSix Inc. (0001673985) (Issuer)

    9/8/25 5:18:08 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SVP, General Counsel Kintiroglou Achilles B. sold $12,105 worth of shares (571 units at $21.20), decreasing direct ownership by 2% to 30,842 units (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    9/3/25 4:31:01 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AdvanSix Appoints Dana O'Brien and Daryl Roberts to Board of Directors

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Dana O'Brien and Daryl Roberts as new independent members of its Board of Directors. Ms. O'Brien recently retired as Senior Vice President and Chief Legal Officer of Olin Corporation, a leading vertically integrated global manufacturer and distributor of chemical products. Ms. O'Brien will serve on the Nominating and Governance Committee and the Compensation and Leadership Development Committee of the Board. Mr. Roberts is currently Senior Vice President and Chief Operations and Engineering Officer of DuPont de Nemours Inc., a global innovation leader with technology-based materials and solutions t

    9/2/25 4:15:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Announces Second Quarter 2025 Financial Results

    2Q25 Sales of $410 million, down 10% versus prior year 2Q25 Earnings Per Share of $1.15; Adjusted Earnings Per Share of $1.24 2Q25 Cash Flow from Operations of $21 million $8 million of 45Q carbon capture tax credits claimed in 2Q25 AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the second quarter ending June 30, 2025. Overall, the Company delivered resilient earnings with strong sequential improvement and executed key growth and enterprise initiatives to support long-term sustainable performance. Second Quarter 2025 Summary "Our resilient second quarter results reflect our collective organization's execution and the advantages of

    8/1/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix to Release Second Quarter Financial Results and Hold Investor Conference Call on August 1

    AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its second quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, August 1. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's second quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on August 1 until 12 noon ET on August 8. You can listen to the replay by dialing (87

    7/11/25 6:50:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Newman Donald P bought $149,089 worth of shares (5,030 units at $29.64) (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    11/19/24 4:20:20 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    SEC Filings

    View All

    AdvanSix Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - AdvanSix Inc. (0001673985) (Filer)

    9/2/25 4:21:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form 144 filed by AdvanSix Inc.

    144 - AdvanSix Inc. (0001673985) (Subject)

    8/1/25 5:16:01 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by AdvanSix Inc.

    10-Q - AdvanSix Inc. (0001673985) (Filer)

    8/1/25 4:10:40 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AdvanSix upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded AdvanSix from Neutral to Overweight and set a new price target of $32.00

    5/19/25 8:45:52 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded AdvanSix from Overweight to Neutral and set a new price target of $26.00

    4/7/25 8:48:39 AM ET
    $ASIX
    Major Chemicals
    Industrials

    Piper Sandler initiated coverage on AdvanSix with a new price target

    Piper Sandler initiated coverage of AdvanSix with a rating of Overweight and set a new price target of $58.00

    11/12/21 4:57:29 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Leadership Updates

    Live Leadership Updates

    View All

    AdvanSix Appoints Dana O'Brien and Daryl Roberts to Board of Directors

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Dana O'Brien and Daryl Roberts as new independent members of its Board of Directors. Ms. O'Brien recently retired as Senior Vice President and Chief Legal Officer of Olin Corporation, a leading vertically integrated global manufacturer and distributor of chemical products. Ms. O'Brien will serve on the Nominating and Governance Committee and the Compensation and Leadership Development Committee of the Board. Mr. Roberts is currently Senior Vice President and Chief Operations and Engineering Officer of DuPont de Nemours Inc., a global innovation leader with technology-based materials and solutions t

    9/2/25 4:15:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Appoints Sidd Manjeshwar as Senior Vice President and Chief Financial Officer

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Sidd Manjeshwar as Senior Vice President and Chief Financial Officer, effective October 1st. In this role, Mr. Manjeshwar will have global responsibility for controllership, treasury, investor relations, procurement, internal audit, commercial finance, tax and financial planning and analysis for the enterprise. Mr. Manjeshwar will report directly to Erin Kane, President and CEO of AdvanSix, and be a member of the Company's executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911629335/en/Sidd Manjeshwar, incoming SVP

    9/12/24 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Appoints Donald P. Newman to Board of Directors

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Donald P. Newman as a new independent member of its Board of Directors. Mr. Newman is currently Executive Vice President, Finance and Chief Financial Officer of ATI Inc., a global producer of high-performance materials and solutions for the global aerospace and defense markets and critical applications in electronics, medical and specialty energy. Mr. Newman will serve on the Audit Committee and the Health, Safety and Environmental Committee of the Board of Directors. AdvanSix's Board now consists of nine members, including eight independent directors. "Don is well recognized for his financial expert

    8/19/24 4:30:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Financials

    Live finance-specific insights

    View All

    AdvanSix Announces Second Quarter 2025 Financial Results

    2Q25 Sales of $410 million, down 10% versus prior year 2Q25 Earnings Per Share of $1.15; Adjusted Earnings Per Share of $1.24 2Q25 Cash Flow from Operations of $21 million $8 million of 45Q carbon capture tax credits claimed in 2Q25 AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the second quarter ending June 30, 2025. Overall, the Company delivered resilient earnings with strong sequential improvement and executed key growth and enterprise initiatives to support long-term sustainable performance. Second Quarter 2025 Summary "Our resilient second quarter results reflect our collective organization's execution and the advantages of

    8/1/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix to Release Second Quarter Financial Results and Hold Investor Conference Call on August 1

    AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its second quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, August 1. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's second quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on August 1 until 12 noon ET on August 8. You can listen to the replay by dialing (87

    7/11/25 6:50:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Announces First Quarter 2025 Financial Results

    1Q25 Sales of $378 million, up 12% versus prior year 1Q25 Earnings Per Share of $0.86; Adjusted Earnings Per Share of $0.93 1Q25 Cash Flow from Operations of $11 million, up $48 million versus prior year 1Q25 results include previously announced $26 million final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the first quarter ending March 31, 2025. Overall, year-over-year results reflect improved operational performance, continued strength in Plant Nutrients, and the previously announced insurance settlement proceeds. First Quarter 2025 Summary Sales up approximately

    5/2/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

    SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

    2/13/24 4:55:58 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

    SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

    2/9/24 9:58:57 AM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by AdvanSix Inc.

    SC 13G - AdvanSix Inc. (0001673985) (Subject)

    2/7/24 8:39:58 AM ET
    $ASIX
    Major Chemicals
    Industrials